|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, Ohio
Recent reports have documented a functional deficit of organic cation transport in diabetic rats by an unknown mechanism. This study was designed to test the hypothesis that experimental diabetes decreases expression of organic cation transporters at the basolateral membrane. Streptozotocin-induced diabetic rats were maintained for varying durations after induction of diabetes. A second group of age-matched control rats was maintained in a parallel manner. Kinetic analysis of tetraethylammonium accumulation in freshly isolated proximal tubular cells indicated a significantly lower Vmax value for the diabetics versus controls with no statistical difference in Km values between the two groups. Cortex sections were processed by standard procedures for Northern and immunoblot analysis. Protein expression of the organic cation transporters rOCT1 and rOCT2 progressively decreased with increasing duration of diabetes. After 21 days of diabetes, rOCT1 and rOCT2 were maximally reduced by 50 and 70%, respectively. Quantification of mRNA expression revealed that the roct1 transcript remained unchanged, whereas the roct2 transcript was decreased by 50% after 14 days of diabetes. Treatment with insulin prevented the reductions in transporter levels. These results support the hypothesis by demonstrating that experimental diabetes decreased expression of both rOCT1 and rOCT2 protein and also of roct2 mRNA accumulation. On the other hand, roct1 mRNA levels were unaffected by the diabetic state. This suggests that differences in rOCT2 protein may result from transcriptional and/or translational changes, whereas rOCT1 deficits may be due to posttranscriptional alterations.
Address correspondence to: Dr. William Cacini, College of Pharmacy, University of Cincinnati Medical Center, 3223 Eden Ave., Cincinnati, OH 45267-0004. E-mail: william.cacini{at}uc.edu
This article has been cited by other articles:
![]() |
Q.-H. Hu, C. Wang, J.-M. Li, D.-M. Zhang, and L.-D. Kong Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement Am J Physiol Renal Physiol, October 1, 2009; 297(4): F1080 - F1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pelis, R. C. Hartman, S. H. Wright, T. M. Wunz, and C. E. Groves Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti, J. S. Petrick, and C. D. Klaassen TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE Drug Metab. Dispos., March 1, 2006; 34(3): 477 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ciarimboli, T. Ludwig, D. Lang, H. Pavenstadt, H. Koepsell, H.-J. Piechota, J. Haier, U. Jaehde, J. Zisowsky, and E. Schlatter Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2 Am. J. Pathol., December 1, 2005; 167(6): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Thomas, C. Tikellis, P. Kantharidis, W. C. Burns, M. E. Cooper, and J. M. Forbes The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 456 - 466. [Abstract] [Full Text] [PDF] |
||||